Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMIMVEX)

Drug Name	MMI-0100 DMIMVEX
Synonyms	Peptide MAPKAPK2 inhibitors (inflammation/scarring/fibrosis), Moerae Matrix; Peptide MK2 inhibitors (inflammation/scarring/fibrosis), Moerae Matrix

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Airway inflammation	DIS8WIR9	CA05	Phase 1	[1]
------------------------------------------------------------------------------------

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Fibrosis	DIS6FM27	GA14-GC01	Investigative	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02515396) Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide (LPS). U.S. National Institutes of Health.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2094).